肠道微生物与恶性肿瘤关系的研究进展
摘要
关键词
全文:
PDF参考
Chase D, Goulder A, Zenhausern F, et al. The vaginal and gastrointestinal microbiomes in gynecologic cancers: a review of applications in etiology, symptoms and treatment[J]. Gynecol Oncol, 2015,138(1):190-200.
Cheng WY, Wu CY, Yu J. The role of gut microbiota in cancer treatment: friend or foe?[J]. Gut, 2020,69(10):1867-1876.
Park EM, Chelvanambi M, Bhutiani N, et al. Targeting the gut and tumor microbiota in cancer[J]. Nat Med, 2022,28(4):690-703.
Ye X, Wang A, Lin W, et al. The Role of Intestinal Flora in Anti-Tumor Antibiotic Therapy[J]. Front Biosci (Landmark Ed), 2022,27(10):281.
Baffy G. Gut Microbiota and Cancer of the Host: Colliding Interests[J]. Adv Exp Med Biol, 2020,1219:93-107.
Trivedi R, Barve K. Gut microbiome a promising target for management of respiratory diseases[J]. Biochem J, 2020,477(14):2679-2696.
Dobson A, Cotter PD, Ross RP, et al. Bacteriocin production: a probiotic trait?[J]. Appl Environ Microbiol, 2012,78(1):1-6.
Shen W, Tang D, Deng Y, et al. Association of gut microbiomes with lung and esophageal cancer: a pilot study[J]. World J Microbiol Biotechnol. 2021,37(8):128.
Wang S, Liu K, Seneviratne CJ, et al. Lipoteichoic acid from an Enterococcus faecalis clinical strain promotes TNF-α expression through the NF-κB and p38 MAPK signaling pathways in differentiated THP-1 macrophages[J]. Biomed Rep, 2015,3(5):697-702.
焦倩倩,朱继伟,潘磊.肠道菌群与肺癌相关研究进展[J].现代肿瘤医学,2024,32(3):569-576.
Khatoon J, Rai RP, Prasad KN. Role of Helicobacter pylori in gastric cancer: Updates[J]. World J Gastrointest Oncol, 2016,8(2):147-158.
Yahiro K, Akazawa Y, Nakano M, et al. Helicobacter pylori VacA induces apoptosis by accumulation of connexin 43 in autophagic vesicles via a Rac1/ERK-dependent pathway[J]. Cell Death Discov, 2015,1:15035.
Maldonado-Contreras A, Goldfarb KC, Godoy-Vitorino F, et al. Structure of the human gastric bacterial community in relation to Helicobacter pylori status[J]. ISME J, 2011,5(4):574-579.
Vinasco K, Mitchell HM, Kaakoush NO, et al. Microbial carcinogenesis: Lactic acid bacteria in gastric cancer[J]. Biochim Biophys Acta Rev Cancer, 2019,1872(2):188309.
San-Millán I, Brooks GA. Reexamining cancer metabolism: lactate production for carcinogenesis could be the purpose and explanation of the Warburg Effect[J]. Carcinogenesis, 2017,38(2):119-133.
Bullman S, Pedamallu CS, Sicinska E, et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer[J]. Science, 2017,358(6369):1443-1448.
Rubinstein MR, Baik JE, Lagana SM, et al. Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β-catenin modulator Annexin A1[J]. EMBO Rep, 2019,20(4):e47638.
Pleguezuelos-Manzano C, Puschhof J, Rosendahl Huber A, et al. Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli[J]. Nature. 2020,580(7802):269-273.
Baker JM, Al-Nakkash L, Herbst-Kralovetz MM. Estrogen-gut microbiome axis: Physiological and clinical implications[J]. Maturitas, 2017,103:45-53.
You L, Cui H, Zhao F, et al. Inhibition of HMGB1/RAGE axis suppressed the lipopolysaccharide (LPS)-induced vicious transformation of cervical epithelial cells[J]. Bioengineered, 2021,12(1):4995-5003.
Chang L, Qiu L, Lei N, et al. Characterization of fecal microbiota in cervical cancer patients associated with tumor stage and prognosis[J]. Front Cell Infect Microbiol, 2023,13:1145950.
Wang Z, Wang Q, Zhao J, et al. Altered diversity and composition of the gut microbiome in patients with cervical cancer[J]. AMB Express, 2019 Mar 23,9(1):40.
Sims TT, Colbert LE, Zheng J, et al. Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls[J]. Gynecol Oncol, 2019 Nov,155(2):237-244.
DOI: http://dx.doi.org/10.12345/yzlcyxzz.v7i10.21655
Refbacks
- 当前没有refback。
此作品已接受知识共享署名-非商业性使用 4.0国际许可协议的许可。